METASTASES TO BREAST

This adverse event was reported 332 times

These drugs are most commonly taken by patients reporting METASTASES TO BREAST:

# Drug Count
0 RIBOCICLIB 57
1 FULVESTRANT 43
2 TRASTUZUMAB 37
3 ANASTROZOLE 36
4 ANASTROZOLE TABLETS 35
5 CAPECITABINE 31
6 DOXORUBICIN 28
7 CISPLATIN 27
8 LETROZOLE 27
9 CARBOPLATIN 24
See all common drugs associated with METASTASES TO BREAST

METASTASES TO BREAST is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RIBOCICLIB 57 0.0017
1 ANASTROZOLE TABLETS 35 0.0016
2 DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG 1 0.0013
3 SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG 1 0.0013
4 FULVESTRANT 43 0.0013
5 ADO-TRASTUZUMAB EMTANSINE 9 0.0011
6 DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG 1 0.0011
7 ANASTROZOLE 36 0.0010
8 DACTINOMYCIN 2 0.0009
9 EVEROLIMUS TABLETS 13 0.0008
See all drugs enriched for association with METASTASES TO BREAST

These drug classes are most commonly taken by patients reporting METASTASES TO BREAST:

# Drug class Count
See all common drug classes associated with METASTASES TO BREAST

METASTASES TO BREAST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
See all drug classes enriched for association with METASTASES TO BREAST